These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24056070)

  • 1. Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction.
    Iversen J; Wand H; Topp L; Kaldor J; Maher L
    AIDS; 2014 Jan; 28(2):275-8. PubMed ID: 24056070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995-2009.
    Topp L; Day CA; Iversen J; Wand H; Maher L;
    AIDS; 2011 Mar; 25(6):835-42. PubMed ID: 21192232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low dead-space syringes for preventing HIV among people who inject drugs: promise and barriers.
    Zule WA
    Curr Opin HIV AIDS; 2012 Jul; 7(4):369-75. PubMed ID: 22627710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling integrated antiretroviral treatment and harm reduction services on HIV and overdose among people who inject drugs in Tijuana, Mexico.
    Cepeda JA; Bórquez A; Magana C; Vo A; Rafful C; Rangel G; Medina-Mora ME; Strathdee S; Martin NK
    J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25493. PubMed ID: 32562375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.
    Vasylyeva TI; Friedman SR; Lourenco J; Gupta S; Hatzakis A; Pybus OG; Katzourakis A; Smyrnov P; Karamitros T; Paraskevis D; Magiorkinis G
    AIDS; 2016 Nov; 30(18):2885-2890. PubMed ID: 27824626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts.
    Huang YF; Yang JY; Nelson KE; Kuo HS; Lew-Ting CY; Yang CH; Chen CH; Chang FY; Liu HR
    PLoS Med; 2014 Apr; 11(4):e1001625. PubMed ID: 24714449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of HIV epidemics driven by men who have sex with men and people who inject drugs.
    Wilson DP; Zhang L
    Curr Opin HIV AIDS; 2011 Mar; 6(2):94-101. PubMed ID: 21505382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward.
    Boltaev AA; El-Bassel N; Deryabina AP; Terlikbaeva A; Gilbert L; Hunt T; Primbetova S; Strathdee SA
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S41-7. PubMed ID: 24103128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland.
    Allen EJ; Palmateer NE; Hutchinson SJ; Cameron S; Goldberg DJ; Taylor A
    Int J Drug Policy; 2012 Sep; 23(5):346-52. PubMed ID: 22940142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
    Marotta PL; McCullagh CA
    Int J Drug Policy; 2016 Jun; 32():3-10. PubMed ID: 27212656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. People who inject drugs in prison: HIV prevalence, transmission and prevention.
    Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.
    Escudero DJ; Lurie MN; Mayer KH; Weinreb C; King M; Galea S; Friedman SR; Marshall BD
    AIDS; 2016 Oct; 30(16):2537-2544. PubMed ID: 27490641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West.
    Uusküla A; Raag M; Folch C; Prasad L; Karnite A; van Veen MG; Eritsyan K; Rosinska M; Des Jarlais DC; Wiessing L
    AIDS; 2014 Jul; 28(11):1657-64. PubMed ID: 25232900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engaging people who inject drugs and their peers in HIV testing and harm reduction in Ukraine: do they make a difference?
    Kravchenko N; Denisiuk O; Kuznetsova J; Jayaraj J; Zachariah R; Smyrnov P
    J Infect Dev Ctries; 2019 Jul; 13(7.1):118S-125S. PubMed ID: 32065814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.
    Meylakhs P; Aasland A; Grønningsæter A
    Harm Reduct J; 2017 Jun; 14(1):33. PubMed ID: 28583120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.